
3D printing company Stratasys (NASDAQ:SSYS) fell short of the market’s revenue expectations in Q2 CY2026, with sales flat year on year at $137.6 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $570 million at the midpoint. Its non-GAAP profit of $0.03 per share was $0.02 above analysts’ consensus estimates.
Is now the time to buy SSYS? Find out in our full research report (it’s free for active Edge members).
Stratasys’ second quarter results saw steady sales, with management highlighting a record quarter for consumables—materials used in 3D printers for manufacturing end-use parts. CEO Yoav Zeif pointed to strong momentum in aerospace and defense as a key driver, noting, “A&D is our largest business by far,” and emphasizing recurring demand from customers like the U.S. Air Force for qualified production parts. The company also credited disciplined cost management and operational rigor as supporting factors in the quarter’s performance.
Looking ahead, Stratasys’ guidance is shaped by continued growth in manufacturing-focused revenue streams and the pending MarkForged acquisition. Zeif emphasized that integrating MarkForged’s carbon fiber technology will expand the company’s presence in aerospace, defense, and industrial production. He added, “MarkForged will enable us to say yes to more new business faster, especially in aerospace, defense and automotive.” Management remains focused on capitalizing on what it describes as a structural shift toward additive manufacturing for mission-critical applications.
Management attributed this quarter’s performance to rising demand for manufacturing-focused consumables, momentum in aerospace and defense, and multi-year agreements with key customers.
Stratasys’ outlook centers on expanding its manufacturing footprint, integrating new technologies, and maintaining cost controls while targeting growth in key verticals.
In the coming quarters, our analysts will focus on (1) the pace and success of integrating MarkForged and realizing expected revenue synergies, (2) sustained growth in aerospace and defense as new programs scale, and (3) the rollout and adoption of Stratasys’ dental solutions in key markets. Additionally, we will watch for evidence that the company is converting its robust pipeline into large, recurring manufacturing deals.
Stratasys currently trades at $9.09, up from $8.84 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.